{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["25(1)"],"submitter":["Doveson S"],"funding":["Sophiahemmet University College"],"pubmed_abstract":["Background
In the fast-expanding field of life-prolonging-treatment of metastatic, castration-resistant prostate cancer, treatment decision-making is very complex - both for patients and healthcare professionals since there is no \"one size that fits all\" in choosing treatment in this phase. Little research has been conducted about men's experiences of treatment decision-making in this advanced, incurable, phase. Hence, this study aimed to describe men's experiences of decision-making in life-prolonging treatments of metastatic castration-resistant prostate cancer.Methods
Seventeen men were recruited from four oncology clinics in Sweden and interviewed at baseline. Qualitative interviews (n = 31) were conducted over two years, the timepoints for subsequent interviews (10 men"],"journal":["BMC medical informatics and decision making"],"pagination":["153"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11960004"],"repository":["biostudies-literature"],"pubmed_title":["Men's experiences of decision-making in life-prolonging treatments of metastatic castration-resistant prostate cancer - wishing for a process adapted to personal preferences: a prospective interview study."],"pmcid":["PMC11960004"],"pubmed_authors":["Wennman-Larsen A","Doveson S","Fransson P","Axelsson L"],"additional_accession":[]},"is_claimable":false,"name":"Men's experiences of decision-making in life-prolonging treatments of metastatic castration-resistant prostate cancer - wishing for a process adapted to personal preferences: a prospective interview study.","description":"Background
In the fast-expanding field of life-prolonging-treatment of metastatic, castration-resistant prostate cancer, treatment decision-making is very complex - both for patients and healthcare professionals since there is no \"one size that fits all\" in choosing treatment in this phase. Little research has been conducted about men's experiences of treatment decision-making in this advanced, incurable, phase. Hence, this study aimed to describe men's experiences of decision-making in life-prolonging treatments of metastatic castration-resistant prostate cancer.Methods
Seventeen men were recruited from four oncology clinics in Sweden and interviewed at baseline. Qualitative interviews (n = 31) were conducted over two years, the timepoints for subsequent interviews (10 men","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Mar","modification":"2025-06-28T03:05:27.755Z","creation":"2025-06-28T03:05:27.755Z"},"accession":"S-EPMC11960004","cross_references":{"pubmed":["40165198"],"doi":["10.1186/s12911-025-02985-x"]}}